Orchid Pharma Ltd

NSE: ORCHPHARMA · BSE: 524372 · Pharmaceuticals & Biotechnology · 37 announcements

Orchid Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹866.70
Market cap: ₹5,190 Cr
Revenue (annual): ₹811.3 Cr
Net profit (annual): ₹20.55 Cr
P/E (TTM): 598.8×Sector 43.8×
Promoter holding: 74.45%+4.61% QoQ
FII holding: 0.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Other Announcement 5 Board Meeting Date 5 Financial Results 4 Merger & Restructuring 2 Management Change 2 Legal & Regulatory 2 Fund Raise 2 Annual General Meeting 2 Acquisition 2 Partnership 1 New Order Win 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Oct 2026 17:03 IST BSE

PartnershipAlfa Alert

Orchid Pharma Partnership

Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.

Open announcement → Read the story on ALFA News Read the filing ↗